Legend Biotech Corp SEC filings LEGN
Legend Biotech Corp has 386 filings in SEC EDGAR's recent list, going back to Mar 9, 2020. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2023 | — |
| CORRESP | Letter to the SEC | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2023 | — |
| D | Filing | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 11, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2022 | — |
| CORRESP | Letter to the SEC | Sep 30, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2022 | — |
| EFFECT | Filing | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2021 | — |
| EFFECT | Filing | Jun 4, 2020 | — |
| EFFECT | Filing | Jun 4, 2020 | — |
| CERT | Filing | Jun 3, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| 8-A12B | Filing | Jun 2, 2020 | — |
| CORRESP | Letter to the SEC | May 21, 2020 | — |
| UPLOAD | Letter from the SEC | May 20, 2020 | — |
| CORRESP | Letter to the SEC | May 19, 2020 | — |
| DRSLTR | Filing | May 8, 2020 | — |
| DRS/A | Filing | May 8, 2020 | — |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| DRSLTR | Filing | Apr 20, 2020 | — |
| DRS/A | Filing | Apr 20, 2020 | — |
| D | Filing | Apr 7, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2020 | — |
| DRS | Filing | Mar 9, 2020 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Somerset, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1801198
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.